Theralase Technologies Inc
XTSX:TLT
Theralase Technologies Inc
Revenue
Theralase Technologies Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theralase Technologies Inc
XTSX:TLT
|
Revenue
CA$1.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-1%
|
|
Neovasc Inc
TSX:NVCN
|
Revenue
$3.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
Profound Medical Corp
TSX:PRN
|
Revenue
$7.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Opsens Inc
TSX:OPS
|
Revenue
CA$48.4m
|
CAGR 3-Years
18%
|
CAGR 5-Years
15%
|
CAGR 10-Years
20%
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Revenue
CA$24.8m
|
CAGR 3-Years
44%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
MedMira Inc
XTSX:MIR
|
Revenue
CA$407.8k
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-14%
|
See Also
What is Theralase Technologies Inc's Revenue?
Revenue
1.1m
CAD
Based on the financial report for Dec 31, 2023, Theralase Technologies Inc's Revenue amounts to 1.1m CAD.
What is Theralase Technologies Inc's Revenue growth rate?
Revenue CAGR 10Y
-1%
Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Theralase Technologies Inc have been 5% over the past three years , -9% over the past five years , and -1% over the past ten years .